Contact Us for Best Myelodysplastic Syndromes (MDS) Treatment Hospitals in India

Best Myelodysplastic Syndromes (MDS) Treatment Hospitals in India

Myelodysplastic Syndromes (MDS) require specialized hematology and transplant facilities equipped with advanced diagnostic labs and immunotherapy units. The Best Myelodysplastic Syndromes (MDS) Treatment Hospitals in India are globally renowned for providing precision diagnostics, state-of-the-art stem cell transplantation, and internationally approved drug therapies for MDS.

Here are some of the Best Myelodysplastic Syndromes (MDS) Treatment Hospitals in India, trusted worldwide for their expertise, advanced facilities, and outstanding patient outcomes.

Indraprastha Apollo Hospital, New Delhi

location Indraprastha Apollo Hospital, NH-19, New Delhi

26

Specialities

710

Beds Facility

138

ICU Beds

1996

Established in

Medanta-The Medicity Gurgaon

location CH Baktawar Singh Rd, Medicity, Islampur Colony, Sector 38, Gurugram, Haryana 122001

27

Specialities

1391+

Beds Facility

271+

ICU Beds

2009

Established in

Fortis Memorial Research Institute (FMRI) Gurugram

location Sector - 44, Opposite HUDA City Centre, Gurugram, Haryana 122002

26

Specialities

330+

Beds Facility

99+

ICU Beds

2001

Established in

BLK-Max Super Speciality Hospital, New Delhi

location Pusa Rd, Radha Soami Satsang, Rajinder Nagar, New Delhi, Delhi – 110005

26

Specialities

650+

Beds Facility

162+

ICU Beds

1959

Established in

Artemis Hospital, Gurgaon

location Sector 51, Gurugram, Bindapur, Haryana – 122001

26

Specialities

750

Beds Facility

185

ICU Beds

2007

Established in

Contact Us for Best Myelodysplastic Syndromes (MDS) Treatment Hospitals in India

Gleneagles Global Health City, Chennai

location 439, Cheran Nagar, Sholinganallur, Perumbakkam, Chennai, Tamil Nadu 600100

26

Specialities

2100

Beds Facility

0

ICU Beds

0

Established in

KD Hospital, Ahmedabad

location Vaishnodevi Circle, Ahmedabad, Gujarat

26

Specialities

300

Beds Facility

0

ICU Beds

0

Established in

Metro Heart Institute with Multispeciality, Faridabad

location Metro Heart Institute Sector 16 A, Faridabad (NCR) – 121002

26

Specialities

400

Beds Facility

30

ICU Beds

0

Established in

Manipal Hospital, Dwarka, New Delhi

location Sector 6 Dwarka, Dwarka, Delhi, 110075

26

Specialities

380+

Beds Facility

118+

ICU Beds

2018

Established in

Amrita Hospital, Faridabad

location Amrita Hospital, Faridabad, Haryana

26

Specialities

2600

Beds Facility

534

ICU Beds

2022

Established in

Contact Us for Best Myelodysplastic Syndromes (MDS) Treatment Hospitals in India

What are Myelodysplastic Syndromes (MDS)?

Myelodysplastic Syndromes (MDS) are a group of bone marrow disorders in which the marrow does not produce enough healthy blood cells. This can lead to anemia, infections, bleeding problems, and in some cases progression to acute leukemia.

 

Why should MDS be treated in specialized hospitals?

MDS management requires:

Advanced bone marrow diagnostics and genetic testing

Access to hematology, oncology, and transplant specialists

Immunotherapy and targeted treatment options

Infection-controlled transplant and ICU facilities

Specialized hospitals provide the comprehensive care needed for accurate diagnosis and effective treatment.

 

Which hospitals in India are known for MDS treatment?

Leading multispecialty and transplant hospitals in New Delhi, Gurugram, Chennai, Ahmedabad, Faridabad, and Dwarka are internationally trusted for providing modern MDS diagnosis, drug therapy, and stem cell transplantation.

 

Are these hospitals internationally accredited?

Yes. Most top MDS treatment centers in India hold NABH, NABL, and international accreditations, ensuring global standards of patient safety, laboratory quality, and clinical outcomes.

 

What diagnostic facilities are available for MDS in these hospitals?

Advanced hospitals provide:

Complete blood counts and peripheral smear

Bone marrow aspiration and biopsy

Cytogenetic and molecular genetic testing

Flow cytometry and immunophenotyping
These tests help determine MDS subtype, risk category, and treatment strategy.